Mercachem logo voor websites

Update COVID-19:

The COVID-19 situation is currently impacting most of the globe, including Asia, Europe and North America. At all MercachemSyncom sites, we follow the recommendations of the local competent authorities as they are released. We have established a series of contingency measures aimed at reducing risks for our employees, their families and the MercachemSyncom Operations. These measures are proactively being reassessed at regular intervals and adapted as deemed appropriate.

The MercachemSyncom team is united and determined to face the situation with the energy, strength and passion that constitute one of our hallmarks.

MercachemSyncom announces the acquisition of Chiralix 1

Mercachem and Syncom are pleased to announce the acquisition of Chiralix; a specialist company in chiral organic synthesis.

This new addition to the MercachemSyncom group of companies broadens the offering of chiral technologies by the company and extends the unique chiral compounds available from the Chiralix compound catalogue. Moreover, MercachemSyncom can now develop flexible and efficient synthetic routes to diversely substituted chiral molecules, such as specialty amino acids, azido acids, amino alcohols, and peptide building blocks.

Richard Blaauw, CEO of Chiralix, commented, “We are thrilled that our catalogue portfolio, as well as the underlying technologies, can be further developed within the MercachemSyncom group. This acquisition enables us to expand on our offerings and provide an increasingly attractive product range to our clients.”

Frank Leemhuis, Managing Director of Mercachem, added, “The Chiralix offerings and technologies nicely complement the current services portfolio, and further strengthen our position as a leading chemistry service provider.”


Full Press Release